These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9548739)

  • 1. A new class of HIV-1 Tat antagonist acting through Tat-TAR inhibition.
    Hamy F; Brondani V; Flörsheimer A; Stark W; Blommers MJ; Klimkait T
    Biochemistry; 1998 Apr; 37(15):5086-95. PubMed ID: 9548739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of protein-RNA complexation that target the RNA: specific recognition of human immunodeficiency virus type 1 TAR RNA by small organic molecules.
    Mei HY; Cui M; Heldsinger A; Lemrow SM; Loo JA; Sannes-Lowery KA; Sharmeen L; Czarnik AW
    Biochemistry; 1998 Oct; 37(40):14204-12. PubMed ID: 9760258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha,alpha-trehalose derivatives bearing guanidino groups as inhibitors to HIV-1 Tat-TAR RNA interaction in human cells.
    Wang M; Xu Z; Tu P; Yu X; Xiao S; Yang M
    Bioorg Med Chem Lett; 2004 May; 14(10):2585-8. PubMed ID: 15109657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a polyethylene glycol-peptide conjugate in a competition gel shift assay for screening potential antagonists of HIV-1 Tat protein binding to TAR RNA.
    Wang J; Huang SY; Choudhury I; Leibowitz MJ; Stein S
    Anal Biochem; 1995 Dec; 232(2):238-42. PubMed ID: 8747481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New inhibitors of the Tat-TAR RNA interaction found with a "fuzzy" pharmacophore model.
    Renner S; Ludwig V; Boden O; Scheffer U; Göbel M; Schneider G
    Chembiochem; 2005 Jun; 6(6):1119-25. PubMed ID: 15883975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orientation and affinity of HIV-1 Tat fragments in Tat-TAR complex determined by fluorescence resonance energy transfer.
    Cao H; Tamilarasu N; Rana TM
    Bioconjug Chem; 2006; 17(2):352-8. PubMed ID: 16536465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA conformation in the Tat-TAR complex determined by site-specific photo-cross-linking.
    Wang Z; Rana TM
    Biochemistry; 1996 May; 35(20):6491-9. PubMed ID: 8639596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA.
    Murchie AI; Davis B; Isel C; Afshar M; Drysdale MJ; Bower J; Potter AJ; Starkey ID; Swarbrick TM; Mirza S; Prescott CD; Vaglio P; Aboul-ela F; Karn J
    J Mol Biol; 2004 Feb; 336(3):625-38. PubMed ID: 15095977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyamidoamine dendrimers inhibit binding of Tat peptide to TAR RNA.
    Zhao H; Li J; Xi F; Jiang L
    FEBS Lett; 2004 Apr; 563(1-3):241-5. PubMed ID: 15063756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 regulatory protein tat induces RNA binding proteins in central nervous system cells that associate with the viral trans-acting-response regulatory motif.
    Kundu M; Ansari SA; Chepenik LG; Pomerantz RJ; Khalili K; Rappaport J; Amini S
    J Hum Virol; 1999; 2(2):72-80. PubMed ID: 10225209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-guided peptidomimetic design leads to nanomolar beta-hairpin inhibitors of the Tat-TAR interaction of bovine immunodeficiency virus.
    Athanassiou Z; Patora K; Dias RL; Moehle K; Robinson JA; Varani G
    Biochemistry; 2007 Jan; 46(3):741-51. PubMed ID: 17223695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tackling Tat.
    Karn J
    J Mol Biol; 1999 Oct; 293(2):235-54. PubMed ID: 10550206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and biological evaluation of novel quinoline derivatives as HIV-1 Tat-TAR interaction inhibitors.
    Chen S; Chen R; He M; Pang R; Tan Z; Yang M
    Bioorg Med Chem; 2009 Mar; 17(5):1948-56. PubMed ID: 19217787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proximity of a Tat peptide to the HIV-1 TAR RNA loop region determined by site-specific photo-cross-linking.
    Wang Z; Huq I; Rana TM
    Bioconjug Chem; 1999; 10(3):512-9. PubMed ID: 10346885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural mimicry of retroviral tat proteins by constrained beta-hairpin peptidomimetics: ligands with high affinity and selectivity for viral TAR RNA regulatory elements.
    Athanassiou Z; Dias RL; Moehle K; Dobson N; Varani G; Robinson JA
    J Am Chem Soc; 2004 Jun; 126(22):6906-13. PubMed ID: 15174860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of 2-phenylquinolones targeted at Tat/TAR recognition.
    Manfroni G; Gatto B; Tabarrini O; Sabatini S; Cecchetti V; Giaretta G; Parolin C; Del Vecchio C; Calistri A; Palumbo M; Fravolini A
    Bioorg Med Chem Lett; 2009 Feb; 19(3):714-7. PubMed ID: 19109014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and SAR of new substituted purines bearing aryl groups at N9 position as HIV-1 Tat-TAR interaction inhibitors.
    Pang R; Zhang C; Yuan D; Yang M
    Bioorg Med Chem; 2008 Sep; 16(17):8178-86. PubMed ID: 18693018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis of HIV-1 TAR RNA specific recognition by an acridine tat-antagonist.
    Gelus N; Hamy F; Bailly C
    Bioorg Med Chem; 1999 Jun; 7(6):1075-9. PubMed ID: 10428376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altering the context of an RNA bulge switches the binding specificities of two viral Tat proteins.
    Smith CA; Crotty S; Harada Y; Frankel AD
    Biochemistry; 1998 Jul; 37(30):10808-14. PubMed ID: 9692971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and bioactivities of TAR RNA targeting beta-carboline derivatives based on Tat-TAR interaction.
    Yu X; Lin W; Pang R; Yang M
    Eur J Med Chem; 2005 Sep; 40(9):831-9. PubMed ID: 15925430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.